Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion type Assertion NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_head.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion wasGeneratedBy ECO_0000203 NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion wasDerivedFrom befree-20140225 NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion SIO_000772 19920204 NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion evidence source_evidence_literature NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.
- NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.